| NKCx Histopathological outcome* within 12 months after cervix cytology in 2020 |
| 777 Skåne |
| Benign | LSIL | HSIL | AIS | Cancer | Other | PAD missing | Total | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cytologi | Antal | Andel | Antal | Andel | Antal | Andel | Antal | Andel | Antal | Andel | Antal | Andel | Antal | Andel | Antal | Andel |
| Benign sample | 87 | 0.5% | 3 | 0.0% | 3 | 0.0% | 1 | 0.0% | 1 | 0.0% | 1 | 0.0% | 17176 | 99.4% | 17272 | 100.0% |
| ASCUS | 755 | 29.4% | 219 | 8.5% | 90 | 3.5% | 9 | 0.4% | 2 | 0.1% | 39 | 1.5% | 1454 | 56.6% | 2568 | 100.0% |
| LSIL | 351 | 24.7% | 264 | 18.6% | 143 | 10.0% | 3 | 0.2% | 2 | 0.1% | 31 | 2.2% | 629 | 44.2% | 1423 | 100.0% |
| Atypical glandular cells/AGC | 9 | 47.4% | . | . | 1 | 5.3% | 6 | 31.6% | 1 | 5.3% | . | . | 2 | 10.5% | 19 | 100.0% |
| Unclear atypia | 3 | 60.0% | . | . | 1 | 20.0% | . | . | . | . | . | . | 1 | 20.0% | 5 | 100.0% |
| ASC-H | 24 | 15.2% | 31 | 19.6% | 77 | 48.7% | 3 | 1.9% | 1 | 0.6% | 2 | 1.3% | 20 | 12.7% | 158 | 100.0% |
| HSIL | 7 | 3.7% | 15 | 8.0% | 138 | 73.4% | 2 | 1.1% | 3 | 1.6% | 4 | 2.1% | 19 | 10.1% | 188 | 100.0% |
| Suspected Adenocarcinom | . | . | . | . | . | . | 6 | 85.7% | 1 | 14.3% | . | . | . | . | 7 | 100.0% |
| Squamous cell cancer | . | . | . | . | . | . | . | . | 1 | 100.0% | . | . | . | . | 1 | 100.0% |
| Totalt | 1236 | 5.7% | 532 | 2.5% | 453 | 2.1% | 30 | 0.1% | 12 | 0.1% | 77 | 0.4% | 19301 | 89.2% | 21641 | 100.0% |
| NOTE: Histopathological outcome from T83x taken into account. |
| This list includes only one diagnosis (the highest ranking) per person, applies to both Cyt and Pad. |
| * Harmonization of PAD codes classification between analysis registry and process registry has been carried out. PAD Class 0 (non diagnostic, unreasonable diagnosis) is excluded, and next PAD counts instead. |
| The classes 2a, b, c and 3a (suspected premalignant, pre-malignant UNS, HPV, suspected malignant) are grouped into 'Other'. |
| Process Registry's Class 1 (benign), 2d (LSIL) and 3b (manifest cancer) have all been introduced without exception. Some codes that occur beyond the scope of the process registry has been added to the different categories. |
| Snomed codes in the category Cancer: |
|---|
| M80703, M81403, M85603 |